Market Cap

Immunotech Biopharm Ltd Market Capitalization:

HK$1.86 Billion

HKD as of July 1, 2024

US$237.6 Million

business Immunotech Biopharm Ltd Company Profile

Immunotech Biopharm Ltd Main Stock Listing

HKEX: 6978

Market Capitalization History of Immunotech Biopharm Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Immunotech Biopharm Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$2.32 B -16.37%
Jan. 1, 2023 HK$2.77 B -21.83%
Jan. 1, 2022 HK$3.54 B -35.93%
Jan. 1, 2021 HK$5.53 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Immunotech Biopharm Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Immunotech Biopharm Ltd has the following listings and related stock indices.


Stock: HKEX: 6978

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.